Neuberger Berman Group LLC trimmed its holdings in Amrize Ltd (NYSE:AMRZ – Free Report) by 53.5% during the third quarter, Holdings Channel.com reports. The fund owned 38,033 shares of the company’s stock after selling 43,824 shares during the period. Neuberger Berman Group LLC’s holdings in Amrize were worth $1,835,000 at the end of the most recent reporting period.
Other hedge funds have also recently added to or reduced their stakes in the company. State of Wyoming acquired a new stake in shares of Amrize in the third quarter valued at approximately $32,000. US Bancorp DE purchased a new stake in Amrize in the 3rd quarter valued at approximately $38,000. Costello Asset Management INC acquired a new stake in Amrize during the 3rd quarter valued at $44,000. Global Retirement Partners LLC acquired a new stake in Amrize during the 3rd quarter valued at $48,000. Finally, Jones Financial Companies Lllp purchased a new position in Amrize during the third quarter worth $53,000.
Insider Buying and Selling at Amrize
In other Amrize news, CFO Ian A. Johnston purchased 1,200 shares of the firm’s stock in a transaction that occurred on Thursday, February 19th. The stock was purchased at an average cost of $63.92 per share, with a total value of $76,704.00. Following the transaction, the chief financial officer owned 18,544 shares in the company, valued at approximately $1,185,332.48. This trade represents a 6.92% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through this link.
Amrize Stock Down 5.4%
Amrize (NYSE:AMRZ – Get Free Report) last posted its quarterly earnings results on Tuesday, February 17th. The company reported $0.62 EPS for the quarter, beating the consensus estimate of $0.59 by $0.03. The business had revenue of $2.84 billion during the quarter, compared to analysts’ expectations of $2.95 billion. The business’s revenue for the quarter was down .4% compared to the same quarter last year.
Wall Street Analysts Forecast Growth
A number of equities analysts have recently weighed in on AMRZ shares. Stephens started coverage on Amrize in a report on Friday, November 14th. They issued an “overweight” rating and a $60.00 price target for the company. JPMorgan Chase & Co. boosted their target price on shares of Amrize from $60.00 to $70.00 and gave the company an “overweight” rating in a research note on Thursday. Deutsche Bank Aktiengesellschaft reaffirmed a “buy” rating on shares of Amrize in a research note on Monday, February 23rd. Oppenheimer reaffirmed an “outperform” rating and issued a $70.00 target price (up from $64.00) on shares of Amrize in a research note on Thursday, February 19th. Finally, Vertical Research began coverage on Amrize in a report on Tuesday, November 25th. They issued a “hold” rating and a $54.00 price target for the company. One investment analyst has rated the stock with a Strong Buy rating, nine have assigned a Buy rating and seven have assigned a Hold rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $64.14.
Read Our Latest Stock Report on AMRZ
Amrize Company Profile
Amrize AG focuses on building materials business in North America. The company was incorporated in 2023 and is based in Zug, Switzerland. Amrize AG operates independently of Holcim AG as of June 23, 2025.
Featured Articles
- Five stocks we like better than Amrize
- “I just bought 10,000 shares of a $5 stock…”
- Buffett, Gates and Bezos Quietly Dumping Stocks—Here’s Why
- How JPMorgan’s $8,000 Gold Call Will Leave Most Retirement Accounts Behind
- Silver Is the New Oil—And the World’s Running Dry
- Nvidia CEO Issues Bold Tesla Call
Want to see what other hedge funds are holding AMRZ? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Amrize Ltd (NYSE:AMRZ – Free Report).
Receive News & Ratings for Amrize Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amrize and related companies with MarketBeat.com's FREE daily email newsletter.
